These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28304313)

  • 1. The Effect of Music Therapy in Patients with Huntington's Disease: A Randomized Controlled Trial.
    van Bruggen-Rufi MC; Vink AC; Wolterbeek R; Achterberg WP; Roos RA
    J Huntingtons Dis; 2017; 6(1):63-72. PubMed ID: 28304313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Music therapy in Huntington's disease: a protocol for a multi-center randomized controlled trial.
    van Bruggen-Rufi M; Vink A; Achterberg W; Roos R
    BMC Psychol; 2016 Jul; 4(1):38. PubMed ID: 27457568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the Music Therapy Assessment Tool for Advanced Huntington's Disease: A Pilot Validation Study.
    O'Kelly J; Bodak R
    J Music Ther; 2016; 53(3):232-56. PubMed ID: 27358245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Use of Music, Dance, and Rhythmic Auditory Cueing for Patients with Huntington's Disease: A Systematic Review.
    Schwartz AE; van Walsem MR; Brean A; Frich JC
    J Huntingtons Dis; 2019; 8(4):393-420. PubMed ID: 31450508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.
    Gonzalez V; Cif L; Biolsi B; Garcia-Ptacek S; Seychelles A; Sanrey E; Descours I; Coubes C; de Moura AM; Corlobe A; James S; Roujeau T; Coubes P
    J Neurosurg; 2014 Jul; 121(1):114-22. PubMed ID: 24702329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising mobility outcome measures in Huntington's disease.
    Busse M; Quinn L; Khalil H; McEwan K
    J Huntingtons Dis; 2014; 3(2):175-88. PubMed ID: 25062860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of music therapy compared with general recreational activities in reducing agitation in people with dementia: a randomised controlled trial.
    Vink AC; Zuidersma M; Boersma F; de Jonge P; Zuidema SU; Slaets JP
    Int J Geriatr Psychiatry; 2013 Oct; 28(10):1031-8. PubMed ID: 23280604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What effect does a structured home-based exercise programme have on people with Huntington's disease? A randomized, controlled pilot study.
    Khalil H; Quinn L; van Deursen R; Dawes H; Playle R; Rosser A; Busse M
    Clin Rehabil; 2013 Jul; 27(7):646-58. PubMed ID: 23426565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Validity of the Short Version of the Problem Behaviours Assessment (PBA-s) for Huntington's disease: A Rasch Analysis.
    McNally G; Rickards H; Horton M; Craufurd D
    J Huntingtons Dis; 2015; 4(4):347-69. PubMed ID: 26756591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.
    Huntington Study Group Reach2HD Investigators
    Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease.
    Cubo E; González M; del Puerto I; de Yébenes JG; Arconada OF; Gabriel y Galán JM;
    Mov Disord; 2012 Mar; 27(3):439-42. PubMed ID: 22162184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancillary Service Utilization and Impact in Huntington's Disease.
    Yomtoob J; Yeh C; Bega D
    J Huntingtons Dis; 2019; 8(3):301-310. PubMed ID: 31177235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies.
    Bachoud-Lévi AC
    Prog Brain Res; 2017; 230():227-261. PubMed ID: 28552231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Decline: Visualising Progression in Huntington's Disease using a Clinical Dashboard with Enroll-HD Data.
    Walker T; Ghosh B; Kipps C
    J Huntingtons Dis; 2017; 6(2):139-147. PubMed ID: 28550266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials.
    Salem L; Saleh N; Youssov K; Olivier A; Charles P; Scherer C; Verny C; Bachoud-Lévi AC; Maison P
    Fundam Clin Pharmacol; 2014 Dec; 28(6):700-10. PubMed ID: 24702447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's Disease.
    McGarry A; Kieburtz K; Abler V; Grachev ID; Gandhi S; Auinger P; Papapetropoulos S; Hayden M
    J Huntingtons Dis; 2017; 6(3):189-199. PubMed ID: 28826192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggression in Huntington's disease: a systematic review of rates of aggression and treatment methods.
    Fisher CA; Sewell K; Brown A; Churchyard A
    J Huntingtons Dis; 2014; 3(4):319-32. PubMed ID: 25575953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease.
    Quinn L; Playle R; Drew CJG; Taiyari K; Williams-Thomas R; Muratori LM; Hamana K; Griffin BA; Kelson M; Schubert R; Friel C; Morgan-Jones P; Rosser A; Busse M;
    Parkinsonism Relat Disord; 2022 Aug; 101():75-89. PubMed ID: 35809488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.